Table 1.
Patient characteristics (N=98)
| Mean | Range | |
|---|---|---|
| Age at diagnosis (years) | 61.5 | 47–79 |
| Gleason Score at diagnosis | 6.6 | 5–9 |
| PSA at diagnosis | 10.2 | 3.5–40 |
| Total no. of treatments received | 1.7 | 1–4 |
| Total no. of incidents reported | 6.4 | 1–22 |
| N | % | |
| Ethnicity | ||
| White | 89 | 90.8 |
| Nonwhite | 9 | 9.2 |
| Disease extent | ||
| Local | 89 | 90.8 |
| Advanced | 9 | 9.2 |
| Time since treatment | ||
| Ongoing | 13 | 13.5 |
| <6 months | 13 | 13.5 |
| 6–12 months | 13 | 13.5 |
| >12 months | 57 | 59.5 |
| Type of treatment | ||
| Multiple treatments | 47 | 48.0 |
| Hormone + external beam RT | 18 | 38.3 |
| Radical prostatectomy + EBRT + hormone | 9 | 19.1 |
| Radical prostatectomy + EBRT | 2 | 4.3 |
| Radical prostatectomy + other therapy | 1 | 2.1 |
| Other multiple treatment | 17 | 36.2 |
| Radical prostatectomy | 25 | 25.5 |
| External beam radiation therapy | 11 | 11.2 |
| Brachytherapy | 7 | 7.1 |
| Hormonal therapy | 5 | 5.1 |
| Other monotherapy | 3 | 3.1 |